TALOTTA, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 2.062
EU - Europa 1.489
AS - Asia 397
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 3.954
Nazione #
US - Stati Uniti d'America 2.055
IE - Irlanda 757
SE - Svezia 414
CN - Cina 296
IT - Italia 153
IN - India 78
BE - Belgio 45
PL - Polonia 28
FI - Finlandia 21
UA - Ucraina 19
DE - Germania 14
FR - Francia 13
GB - Regno Unito 12
CA - Canada 7
IQ - Iraq 6
VN - Vietnam 6
BG - Bulgaria 3
DK - Danimarca 3
TR - Turchia 3
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
IR - Iran 2
KZ - Kazakistan 2
QA - Qatar 2
RU - Federazione Russa 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CL - Cile 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
RO - Romania 1
Totale 3.954
Città #
Dublin 756
Chandler 539
Nyköping 342
Princeton 149
Dearborn 115
Beijing 112
Jacksonville 112
Medford 112
Ann Arbor 90
Des Moines 84
New York 81
Ashburn 78
Pune 70
Brussels 45
Wilmington 41
Cambridge 35
Messina 32
Warsaw 28
Jinan 25
Nanjing 19
Shenyang 19
Zhengzhou 15
Falls Church 14
Washington 13
Catania 12
Ningbo 12
Hebei 11
San Mateo 11
Guangzhou 10
Hangzhou 9
Woodbridge 9
Haikou 8
Boardman 7
Grammichele 7
Nanchang 7
Norwalk 7
Dong Ket 6
Fuzhou 5
Lancaster 5
Redwood City 5
Seattle 5
Bremen 4
Changsha 4
Jiaxing 4
Taizhou 4
Tianjin 4
Bengaluru 3
Gioiosa Marea 3
Hefei 3
Helsinki 3
Iowa City 3
Milwaukee 3
Pisa 3
Reggio Calabria 3
Taiyuan 3
Arco 2
Astana 2
Augusta 2
Basrah 2
Bello 2
Brooklyn 2
Cagliari 2
Changle 2
Clearwater 2
Gela 2
Houston 2
Kunming 2
Lanzhou 2
Los Angeles 2
Lyon 2
Monmouth Junction 2
Plovdiv 2
Redmond 2
Roda 2
Waterbury 2
Albolote 1
Ardabil 1
Avola 1
Ballyhaise 1
Baotou 1
Brisbane 1
Brno 1
Capoterra 1
Chaoyang 1
Chengdu 1
Copenhagen 1
Council Bluffs 1
Dallas 1
Florence 1
Forlì 1
Fossambault-sur-le-Lac 1
Izmir 1
Kemerovo 1
Kingston 1
Kissimmee 1
Laval 1
Milan 1
Milazzo 1
Modica 1
Montréal 1
Totale 3.174
Nome #
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 77
The microbiome in connective tissue diseases and vasculitides: An updated narrative review 73
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 72
effetti dell'acido ialuronico sulla qualità di vita in pazienti affetti da osteoartrosi 71
Densità minerale ossea, parametri ultrasonografici e metabolismo osseo in pazienti affetti da sclerosi sistemica. 66
CARDIOVASCULAR EVALUATION USING NON-INVASIVE IMAGING METHODS IN PATIENTS WITH ANKYLOSING SPONDYLITIS BEFORE AND AFTER 12 MONTHS OF TREATMENT WITH ANTI-TNF DRUGS 65
Algo-dysfunctional syndromes: a critical digest of the recent literature 64
CORRELATION BETWEEN SERUM LEVELS OF SCL-70 AUTO-ANTIBODIES AND SUBCLINICAL LV SYSTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS 62
BODY MASS INDEX, SMOKING STATUS AND RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS: A REAL-LIFE STUDY. 60
SYSTEMIC SCLEROSIS AND CHRONIC GRAFT-VERSUS-HOST DISEASE SCLERODERMA-LIKE HAVE OTHER SIMILAR PATHOGENETIC MECHANISMS THAN STIMULATORY AUTOANTIBODIES TO PDGFR? 56
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab 55
Certainties and uncertainties concerning the contribution of pericytes to the pathogenesis of systemic sclerosis 54
Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors 54
CORRELATION BETWEEN DISEASE ACTIVITY AND CARDIOVASCULAR PARAMETERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS 54
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 52
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 52
Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents 51
Differential Diagnosis of Vasovagal Syncope: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 51
Immunogenicity and autoimmunity during anti-TNF therapy 49
CLINICAL AND ULTRASONOGRAPHIC EVALUATION IN A COHORT OF SUSTAINED REMISSION RHEUMATOID ARTHRITIS PATIENTS AFTER STOPPING BIOLOGIC THERAPY: A SINGLE CENTER EXPERIENCE , 49
Biomarkers in Rheumatoid Arthritis 48
Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study 46
Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical trial 45
Riniti persistenti da un punto di vista immunologico 44
Influence of Polymorphism at Position-308 of the Tumour Necrosis Factor Alpha Gene on the Expression of High Mobility Group Box-1 Protein in Rheumatoid Arthritis and Spondyloarthritis patient. 44
From autoinflammation to autoimmunity: old and recent findings 44
Autoimmunity as the comet tail of COVID-19 pandemic 44
CHRONIC PAIN AND DEPRESSION: PAIN THRESHOLD AND VISUAL ANALOGUE SCALE. 43
THE THRESHOLD OF PAIN IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS CORRELATES WITH ESR BUT NOT WITH ULTRASOUND SCORE. 43
Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and Early Spondyloarthritis. A Monocentric Preliminary Study 43
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: A case series 42
MEASUREMENT OF SERUM ALPHA-KLOTHO IN SYSTEMIC SCLEROSIS PATIENTS: RESULTS FROM A PIVOTAL STUDY. 42
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 42
One year in review 2019: fibromyalgia 41
Retrotransposons shuttling genetic and epigenetic information from the nuclear to the mitochondrial compartment: Do they play a pathogenetic role in scleroderma? 41
The rationale for targeting the JAK/STAT pathway in scleroderma-associated interstitial lung disease 41
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trial 41
Physical activity in idiopathic inflammatory myopathies: two intervention proposals based on literature review 41
Influence of polymorphism -308 G/A of the TNF-α gene on high mobility group BOX-1 protein in rheumatoid and spondylo-arthritis patients 40
Measurement of Serum Klotho in Systemic Sclerosis 40
DOSE REDUCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RESPONDING TO THE STANDARD RITUXIMAB REGIMEN. 40
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset 40
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 40
Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis 40
Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases” 40
Patologie respiratorie allergiche e miceti: casistica personale. 39
THE CORRELATION BETWEEN CTLA4, CD80 AND CD86 GENE POLYMORPHISMS AND CLINICAL RESPONSE IN PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT. 39
The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. 39
ACHILLES PAIN PERSISTENCE IN PATIENTS AFFECTED BY SPONDYLOARTHRITIS: ULTRASONOGRAPHIC AND BIOMECHANICAL STUDY. 39
What are the dangers of biological therapy discontinuation or dose reduction strategies when treating rheumatoid arthritis? 38
Biological agents in rheumatoid arthritis: A cross-link between immune tolerance and immune surveillance 38
Reactivation of occult hepatitis B virus infection under treatment with abatacept: A case report 37
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis 37
Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy 37
GENISTEIN PREVENTS QUALITY OF LIFE OSTEOPENIC POST- MENOPAUSAL WOMENS: A 2-YEAR RANDOMIZED, DOUBLE-BLIND, CONTROLLED-STUDY. 36
PAIN INTENSITY AND THRESHOLD IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS: CORRELATIONS WITH THE HAMILTON DEPRESSION RATING SCALE 36
Reasons Why Patients Failed Vaccinations Vs Influenza and Pneumococcus. Monocentric Cross-Sectional Study 36
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC SALIVARY GLANDS ABNORMALITIES AND SUBCLINICAL CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH PRIMARY SJÖGREN SYNDROME 36
Skin scores of patients with systemic sclerosis correlate with circulating thyrotropin levels 35
Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern? 35
Pain in systemic sclerosis 35
Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data 35
Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response 34
Infections and Biological Therapy in Patients with Rheumatic Diseases 34
SDAI AS PREDICTOR OF 1-YEAR EFFICACY OF THE FIRST TNF BLOCKER IN CLINICAL PRACTICE. 34
Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back? 33
Psoriatic arthritis: From pathogenesis to pharmacologic management 32
Retroviruses in the pathogenesis of systemic lupus erythematosus: Are they potential therapeutic targets? 32
VITAMIN D LEVELS AND BONE MINERAL DENSITY IN SYSTEMIC SCLEROSIS. 30
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 30
PREVALENCE OF CHRONIC WIDESPREAD PAIN IN SSC PATIENTS: PRELIMINARY DATA 30
Vitamin D levels and bone mineral density in systemic sclerosis 29
Glucocorticoidi nell’artrite reumatoide ed esperienze cliniche dell’uso di prednisone a rilascio modificato 29
Rheumatic Diseases and Biosimilars: Evidence about Switch from Originators to Biosimilars in the Real Life 29
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy 28
Novel pharmaceutical options for treating fibromyalgia 27
null 26
The role of klotho in systemic sclerosis 26
Polymorphic alleles in Exon 1 of the CTLA4 gene do not predict the response to abatacept. 25
Pros and cons of the immunogenicity of monoclonal antibodies in cancer treatment: A lesson from autoimmune diseases 25
Ultrasonographic Evaluation of the Enthesis in Patients Affected By Entheropatic Spondiloarthritis. Focus on Distal Enthesis of the Patellar Tendon 24
PARADOXICAL EXPANSION OF TH1 AND TH17 CELLS IN PERIPHERAL CULTURAL BLOOD CELLS OF RA PATIENTS FOLLOWING INFLIXIMAB TREATMENT: A POSSIBLE CORRELATION WITH LOSS OF CLINICAL RESPONSE AND ADVERSE EVENTS 24
IL RUOLO DI KLOTHO NELLA SCLEROSI SISTEMICA 24
EXPRESSION OF HERV-E CLONE 4.1 GAG TRANSCRIPTS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS 24
Spondyloarthritis and Gastrointestinal Involvement 23
THE ROLE OF TH9 LYMPHOCYTES IN RHEUMATOID ARTHRITIS 23
Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes 23
null 22
Fibromialgia 22
Efficacy of Cannabis Flos in Patients with Fibromyalgia: A Monocentric 22
The preventive and therapeutic role of physical activity in knee osteoarthritis 22
Perspectives: potential therapeutic approach with inhalation of ACE2-derived peptides for SARS-CoV-2 infection 21
Pain Intensity and Threshold in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients: Correlations with the Hamilton Depression Rating Scale 20
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 20
Possible relationship between certolizumab pegol and arrhythmias: Report of two cases 20
One year in review 2017: fibromyalgia. 20
PREVALENCE AND EPIDEMIOLOGY OF FAMILIAL MEDITERRANEAN FEVER AND TUMOR NECROSIS FACTORRECEPTOR-ASSOCIATED PERIODIC SYNDROME: RESULTS FROM AN ITALIAN CENTER 20
Pamidronate Treatment of Osteonecrosis of the Hip in Young Male. 19
null 19
null 18
Totale 3.832
Categoria #
all - tutte 16.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 1 5 1 1 1
2019/2020510 7 3 1 12 13 72 202 37 10 63 62 28
2020/2021463 18 7 109 19 112 24 35 53 16 38 19 13
2021/2022666 5 38 17 27 43 17 42 33 14 36 35 359
2022/20232.014 148 195 124 153 71 192 36 105 906 14 51 19
2023/2024428 47 57 24 40 47 195 2 16 0 0 0 0
Totale 4.224